ClinicalTrials.Veeva

Menu

Timing of Tracheostomy in COVID-19 - Impact on Mortality

G

Goethe University

Status

Completed

Conditions

Tracheostomy

Study type

Observational

Funder types

Other

Identifiers

NCT05175859
Tracheostomy in COVID-19

Details and patient eligibility

About

How timing of tracheostomy in COVID-19 patients changed and its impact on mortality in patients with severe COVID-19 ARDS

Enrollment

117 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Severe COVID-19 infection requiring endotracheal intubation and prolonged invasive ventilation as part of the treatment of severe to moderate acute respiratory distress syndrome.

Exclusion criteria

  • COVID-19 disease, without the need for endotracheal ventilation.
  • COVID-19 disease with need for endotracheal intubation with anticipated short-term invasive ventilation.

Trial design

117 participants in 2 patient groups

Early tracheostomy
Description:
Tracheostomy time before day 10 following endotracheal airway management and invasive ventilation.
Late tracheostomy
Description:
Tracheostomy time after day 11 following endotracheal airway management and invasive ventilation.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems